$788 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 21.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QDEL | Buy | QUIDEL CORP | $406,333,000 | +130.0% | 1,816,094 | +0.6% | 51.56% | -1.8% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $147,075,000 | +131.0% | 2,011,700 | +7.5% | 18.66% | -1.3% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $61,685,000 | +80.5% | 4,068,942 | -0.8% | 7.83% | -22.9% |
| OPK | Buy | OPKO HEALTH INC | $41,076,000 | +585.3% | 12,045,886 | +169.3% | 5.21% | +192.6% |
| AWH | New | ASPIRA WOMENS HEALTH INC | $39,508,000 | – | 10,288,587 | +100.0% | 5.01% | – |
| AGEN | Buy | AGENUS INC | $26,419,000 | +101.1% | 6,722,460 | +25.4% | 3.35% | -14.1% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $15,004,000 | +104.3% | 2,168,142 | +18.1% | 1.90% | -12.7% |
| QDEL | Buy | QUIDEL CORPcall | $12,037,000 | +210.5% | 191,300 | +21.5% | 1.53% | +32.6% |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $9,530,000 | – | 2,000,000 | +100.0% | 1.21% | – |
| SLNO | Sell | SOLENO THERAPEUTICS INC | $8,148,000 | -11.6% | 3,670,384 | -5.2% | 1.03% | -62.2% |
| MOTS | MOTUS GI HLDGS INC | $5,028,000 | +96.0% | 3,806,666 | 0.0% | 0.64% | -16.3% | |
| ATRS | Buy | ANTARES PHARMA INC | $4,674,000 | +61.4% | 1,699,566 | +38.5% | 0.59% | -31.0% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $4,555,000 | +22.0% | 1,320,359 | +8.2% | 0.58% | -47.9% |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO Lcall | $2,494,000 | +1044.0% | 63,100 | -36.9% | 0.32% | +386.2% |
| YMAB | Y-MABS THERAPEUTICS INC | $1,089,000 | +65.5% | 25,212 | 0.0% | 0.14% | -29.6% | |
| BIOL | Sell | BIOLASE INC | $1,000,000 | -48.5% | 1,739,100 | -66.4% | 0.13% | -78.0% |
| BIIB | Sell | BIOGEN INC | $987,000 | -35.9% | 3,688 | -24.2% | 0.12% | -72.7% |
| CFRX | CONTRAFECT CORP | $823,000 | +10.9% | 128,845 | 0.0% | 0.10% | -52.7% | |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INCcall | $686,000 | +1147.3% | 137,900 | -64.5% | 0.09% | +443.8% |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -351,000 | -100.0% | -0.00% | – |
| VRML | Exit | VERMILLION INC | $0 | – | -9,825,289 | -100.0% | -2.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.